Prot #A19-11184: Phase I Study of APR-246 in Combination with Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies

Project: Research project

StatusActive
Effective start/end date1/21/201/21/23

Funding

  • Theradex (Prot #A19-11184)
  • Aprea Therapeutics AB (Prot #A19-11184)